Target blood pressure for septic and vasodilatory shock: what is optimal?

Affiliations

¹ Department of Emergency and Critical Care Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
² Department of Emergency and Critical Care Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan. ohshimos@hiroshima-u.ac.jp.
³ Université de Sherbrooke, Sherbrooke, Canada.
⁴ McMaster University, Hamilton, Canada.
⁵ University Hospital of Angers, Angers, France.

Comment

Junki Ishii et al. Intensive Care Med. 2018 Apr.

. 2018 Apr;44(4):548-549.

doi: 10.1007/s00134-018-5127-7. Epub 2018 Mar 12.

¹ Department of Emergency and Critical Care Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
² Department of Emergency and Critical Care Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan. ohshimos@hiroshima-u.ac.jp.
³ Université de Sherbrooke, Sherbrooke, Canada.
⁴ McMaster University, Hamilton, Canada.
⁵ University Hospital of Angers, Angers, France.

No abstract available

Comment on

Pooled analysis of higher versus lower blood pressure targets for vasopressor therapy septic and vasodilatory shock.
Lamontagne F, Day AG, Meade MO, Cook DJ, Guyatt GH, Hylands M, Radermacher P, Chrétien JM, Beaudoin N, Hébert P, D'Aragon F, Meziani F, Asfar P. Lamontagne F, et al. Intensive Care Med. 2018 Jan;44(1):12-21. doi: 10.1007/s00134-017-5016-5. Epub 2017 Dec 19. Intensive Care Med. 2018. PMID: 29260272